Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX2HLC
|
||||
Drug Name |
4-(5-{[2-(2-Chloro-benzyl)-3-oxo-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-ylamino]-methyl}-imidazol-1-ylmethyl)-benzonitrile
|
||||
Synonyms |
CHEMBL423799
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H26ClN5O
|
||||
Canonical SMILES |
Clc1ccccc1CN2Cc3ccccc3CC(NCc4cncn4Cc5ccc(cc5)C#N)C2=O
|
||||
InChI |
InChI=1S/C29H26ClN5O/c30-27-8-4-3-7-25(27)19-34-18-24-6-2-1-5-23(24)13-28(29(34)36)33-16-26-15-32-20-35(26)17-22-11-9-21(14-31)10-12-22/h1-12,15,20,28,33H,13,16-19H2
|
||||
InChIKey |
QQBJGMOFEGWNEB-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.